Earnings estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
No. of analysts | 3 | 2 | 35 | 34 |
Avg. Estimate | 9.1 | 11.4 | 44.92 | 49.98 |
Low estimate | 7.42 | 10.93 | 36.7 | 39.9 |
High estimate | 10.1 | 11.86 | 54.1 | 68.6 |
Year ago EPS | 8.85 | 13.33 | 41.36 | 44.92 |
Revenue estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
No. of analysts | 4 | 2 | 34 | 33 |
Avg. Estimate | 40.4B | 45.03B | 180.72B | 198.7B |
Low estimate | 38.42B | 44.07B | 170.37B | 183.83B |
High estimate | 41.71B | 45.99B | 200.98B | 239.33B |
Year ago sales | 36.21B | 43.54B | 162.33B | 180.72B |
Sales growth (year/est) | 11.60% | 3.40% | 11.30% | 9.90% |
Earnings history | 30/06/2017 | 30/09/2017 | 31/12/2017 | 31/03/2018 |
---|---|---|---|---|
Est. EPS | 9.88 | 11.67 | 11.82 | 10.27 |
Actual EPS | 8.85 | 13.33 | 10.16 | 9.02 |
Difference | -1.03 | 1.66 | -1.66 | -1.25 |
Surprise % | -10.40% | 14.20% | -14.00% | -12.20% |
EPS trend | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
Current estimate | 9.1 | 11.4 | 44.92 | 49.98 |
7 days ago | 9.1 | 11.4 | 45.01 | 50.2 |
30 days ago | 8.76 | 11.4 | 45.1 | 50.15 |
60 days ago | 10.78 | 10.86 | 47.89 | 53.27 |
90 days ago | 10.97 | 11.01 | 47.83 | 53.08 |
EPS revisions | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 2 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | 1 | 1 |
Growth estimates | AUROPHARMA.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 2.80% | N/A | N/A | N/A |
Next qtr. | -14.50% | N/A | N/A | N/A |
Current year | 8.60% | N/A | N/A | N/A |
Next year | 11.30% | N/A | N/A | N/A |
Next 5 years (per annum) | 12.03% | N/A | N/A | N/A |
Past 5 years (per annum) | 38.93% | N/A | N/A | N/A |